gms | German Medical Science

Infektiologie Update 2016: 25. Jahrestagung der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG)

Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG)

06.-08.10.2016, Rostock

The Asp20→ Asn substitution in the response regulator AdeR leads to enhanced efflux activity of AdeB in Acinetobacter baumannii

Meeting Abstract

  • Jennifer Nowak - Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany
  • Thamarai Schneiders - Division of Infection and Pathway Medicine, Edinburgh, United Kingdom
  • Harald Seifert - Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany; German Centre For Infection Research, Bonn-Cologne, Germany
  • Paul G. Higgins - Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany

Infektiologie Update 2016. 25. Jahrestagung der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG). Rostock, 06.-08.10.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. Doc16peg19

doi: 10.3205/16peg19, urn:nbn:de:0183-16peg196

Published: September 30, 2016

© 2016 Nowak et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Overexpression of the resistance-nodulation-cell division-type efflux pump AdeABC is often associated with multidrug resistance in Acinetobacter baumannii and has been linked to mutations in the genes encoding the AdeRS two-component system. In a previous study, we reported the Asp20→Asn amino acid substitution in the response regulator AdeR is associated with adeB overexpression and reduced susceptibility to antimicrobials levofloxacin, tigecycline and trimethoprim-sulfamethoxazole [1]. To further characterise the effect of the Asp20→Asn substitution on antimicrobial susceptibility, the expression of efflux genes adeB, adeJ, adeG, and substrate accumulation, four plasmid constructs [containing adeR(Asp20)S, adeR(Asn20)S, adeR(Asp20)SABC, adeR(Asn20)SABC] were introduced into the adeRSABC-deficient A. baumannii isolate NIPH 60. Neither adeRS construct induced changes in antimicrobial susceptibility or substrate accumulation from that for the vector-only control. The adeR(Asp20)SABC transformant showed reduced susceptibility to 6 antimicrobials and accumulated 12% less ethidium than the control, whereas the Asn20 variant showed reduced susceptibility to 6 of 8 antimicrobial classes tested, and its ethidium accumulation was only 72% of that observed for the vector-only construct. adeB expression was 7-fold higher in the adeR(Asn20)SABC transformant than in its Asp20 variant. No changes in adeG or adeJ expression or in acriflavine or rhodamine 6G accumulations were detected. The antimicrobial susceptibility data suggest that AdeRS does not regulate any resistance determinants other than AdeABC. Furthermore, the characterisation of the Asp20→Asn20 substitution proves that reduced antimicrobial susceptibility previously associated with this substitution was indeed caused by enhanced efflux activity of AdeB.

Table 1 [Tab. 1], Figure 1 [Fig. 1]


References

1.
Higgins PG, Schneiders T, Hamprecht A, Seifert H. In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrob Agents Chemother. 2010;54:5021-7.